Recommended Uniform Screening Panel1
Core2 Conditions3
(as of December 2011)
ACMG Code | Core Condition | Metabolic Disorder |
Endocrine Disorder |
Hemoglobin Disorder |
Other Disorder | ||
|---|---|---|---|---|---|---|---|
Organic acid condition | Fatty acid oxidation disorders | Amino acid disorders | |||||
| PROP | Propionic academia | X | |||||
| MUT | Methylmalonic acidemia (methylmalonyl-CoA mutase) | X | |||||
| Cbl A,B | Methylmalonic acidemia (cobalamin disorders) | X | |||||
| IVA | Isovaleric acidemia | X | |||||
| 3-MCC | 3-Methylcrotonyl-CoA carboxylase deficiency | X | |||||
| HMG | 3-Hydroxy-3-methyglutaric aciduria | X | |||||
| MCD | Holocarboxylase synthase deficiency | X | |||||
| ßKT | ß-Ketothiolase deficiency | X | |||||
| GA1 | Glutaric acidemia type I | X | |||||
| CUD | Carnitine uptake defect/carnitine transport defect | X | |||||
| MCAD | Medium-chain acyl-CoA dehydrogenase deficiency | X | |||||
| VLCAD | Very long-chain acyl-CoA dehydrogenase deficiency | X | |||||
| LCHAD | Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency | X | |||||
| TFP | Trifunctional protein deficiency | X | |||||
| ASA | Argininosuccinic aciduria | X | |||||
| CIT | Citrullinemia, type I | X | |||||
| MSUD | Maple syrup urine disease | X | |||||
| HCY | Homocystinuria | X | |||||
| PKU | Classic phenylketonuria | X | |||||
| TYR I | Tyrosinemia, type I | X | |||||
| CH | Primary congenital hypothyroidism | X | |||||
| CAH | Congenital adrenal hyperplasia | X | |||||
| Hb SS | S,S disease (Sickle cell anemia) | X | |||||
| Hb S/ßTh | S, βeta-thalassemia | X | |||||
| Hb S/C | S,C disease | X | |||||
| BIOT | Biotinidase deficiency | X | |||||
| CCHD | Critical congenital heart disease | X | |||||
| CF | Cystic fibrosis | X | |||||
| GALT | Classic galactosemia | X | |||||
| HEAR | Hearing loss | X | |||||
| SCID | Severe combined immunodeficiences | X | |||||
1. Selection of conditions based upon “Newborn Screening: Towards a Uniform Screening Panel and System.” Genetic Med. 2006; 8(5) Suppl: S12-S252” as authored by the American College of Medical Genetics (ACMG) and commissioned by the Health Resources and Services Administration (HRSA).
2. Disorders that should be included in every Newborn Screening Program.
3. Nomenclature for Conditions based upon “Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels.” Pediatrics. 2006; 117 (5) Suppl: S308-S314.
SACHDNC Recommended Uniform Screening Panel1
Secondary2 Conditions 3
(as of December 2011)
ACMG Code | Secondary Condition | Metabolic Disorder |
Hemoglobin Disorder |
Other Disorder | ||
|---|---|---|---|---|---|---|
Organic acid condition | Fatty acid oxidation disorders | Amino acid disorders | ||||
| Cbl C,D | Methylmalonic acidemia with homocystinuria | X | ||||
| MAL | Malonic acidemia | X | ||||
| IBG | Isobutyrylglycinuria | X | ||||
| 2MBG | 2-Methylbutyrylglycinuria | X | ||||
| 3MGA | 3-Methylglutaconic aciduria | X | ||||
| 2M3HBA | 2-Methyl-3-hydroxybutyric aciduria | X | ||||
| SCAD | Short-chain acyl-CoA dehydrogenase deficiency | X | ||||
| M/SCHAD | Medium/short-chain L-3-hydroxyacl-CoA dehydrogenase deficiency | X | ||||
| GA2 | Glutaric acidemia type II | X | ||||
| MCAT | Medium-chain ketoacyl-CoA thiolase deficiency | X | ||||
| DE RED | 2,4 Dienoyl-CoA reductase deficiency | X | ||||
| CPT IA | Carnitine palmitoyltransferase type I deficiency | X | ||||
| CPT II | Carnitine palmitoyltransferase type II deficiency | X | ||||
| CACT | Carnitine acylcarnitine translocase deficiency | X | ||||
| ARG | Argininemia | X | ||||
| CIT II | Citrullinemia, type II | X | ||||
| MET | Hypermethioninemia | X | ||||
| H-PHE | Benign hyperphenylalaninemia | X | ||||
| BIOPT (BS) | Biopterin defect in cofactor biosynthesis | X | ||||
| BIOPT (REG) | Biopterin defect in cofactor regeneration | X | ||||
| TYR II | Tyrosinemia, type II | X | ||||
| TRY III | Tyrosinemia, type III | X | ||||
| Var Hb | Various other hemoglobinopathies | X | ||||
| GALE | Galactoepimerase deficiency | X | ||||
| GALK | Galactokinase deficiency | X | ||||
| T-cell related lymphocyte deficiencies | X | |||||
1. Selection of conditions based upon “Newborn Screening: Towards a Uniform Screening Panel and System.” Genetic Med. 2006; 8(5) Suppl: S12-S252” as authored by the American College of Medical Genetics (ACMG) and commissioned by the Health Resources and Services Administration (HRSA).
2. Disorders that can be detected in the differential diagnosis of a core disorder.
3. Nomenclature for Conditions based upon “Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels.” Pediatrics. 2006; 117 (5) Suppl: S308-S314.